scispace - formally typeset
Open AccessJournal ArticleDOI

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.

Rolf Hilgenfeld, +1 more
- 01 Oct 2013 - 
- Vol. 100, Iss: 1, pp 286-295
Reads0
Chats0
TLDR
Experts in many different aspects of coronavirus replication and disease will provide authoritative, up-to-date reviews of the following topics: clinical management and infection control of SARS, and the public health legacy of the SARS outbreak.
About
This article is published in Antiviral Research.The article was published on 2013-10-01 and is currently open access. It has received 295 citations till now. The article focuses on the topics: Middle East respiratory syndrome & Coronavirus.

read more

Citations
More filters
Journal ArticleDOI

Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.

TL;DR: Mechanistic pathways for individuals with obesity are presented in depth for factors linked with COVID‐19 risk, severity and their potential for diminished therapeutic and prophylactic treatments among these individuals.
Journal ArticleDOI

Zoonotic origins of human coronaviruses.

TL;DR: An overview of the existing knowledge about the seven HCoVs is presented, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission, and the current CoV disease 2019 (COVID-19) epidemic is discussed.
Journal ArticleDOI

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

TL;DR: Four compounds are identified inhibiting MERS-CoV replication in the low-micromolar range (50% effective concentrations [EC50s], 3 to 8 μM) and may offer a starting point for treatment of patients infected with zoonotic coronavirus infections.
Journal ArticleDOI

Structure of replicating SARS-CoV-2 polymerase.

TL;DR: A cryo-electron microscopy structure of the RNA-dependent RNA polymerase of SARS-CoV-2 sheds light on coronavirus replication and enables the analysis of the inhibitory mechanisms of candidate antiviral drugs.
Journal ArticleDOI

From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

TL;DR: The crystal structure of the free SARS coronavirus Mpro and its dependence on pH is discussed, as are efforts to design inhibitors on the basis of these structures, and the role of X‐ray crystallography in structure‐assisted drug discovery against these targets is discussed.
References
More filters
Journal ArticleDOI

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

TL;DR: It is found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells, indicating that ACE2 is a functional receptor for SARS-CoV.
Journal ArticleDOI

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

TL;DR: The clinical picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.
Journal ArticleDOI

Coronavirus as a possible cause of severe acute respiratory syndrome

TL;DR: Serological and molecular tests specific for the virus permitted a definitive laboratory diagnosis to be made and allowed further investigation to define whether other cofactors play a part in disease progression.
Related Papers (5)